Day: March 4, 2024

Bridgeland®, a Howard Hughes community, named Best Master Planned Community of the Year by NAHBBridgeland®, a Howard Hughes community, named Best Master Planned Community of the Year by NAHBNation’s #5 top-selling community earns two Gold Awards at NAHB International Builders’ Show Bridgeland® joins Summerlin® and Ward Village® as Howard Hughes communities recognized with NAHB top honorHOUSTON, March 04, 2024 (GLOBE NEWSWIRE) — The community of Bridgeland® has been named “Master Planned Community of the Year” by the National Association of Home Builders (NAHB), receiving top honors at The Nationals 2024 awards gala last week in Las Vegas. Bridgeland, an 11,500-acre master planned community in the Greater Houston region developed by Howard Hughes Holdings Inc. (NYSE: HHH), was celebrated for its exceptional quality of...

TORONTO, March 04, 2024 (GLOBE NEWSWIRE) — Xanadu Mines Ltd (ASX:XAM, TSX:XAM) (Xanadu or the Company) is pleased to announce that the placement of 15,185,328 fully paid ordinary shares to Jinping (Singapore) Mining Pte Ltd, a wholly owned indirect subsidiary of Zijin Mining Group Co. Ltd (Zijin), at an issue price of A$0.055 per share, completed today. Details of the proposed placement to Zijin were announced to ASX on 20 November 2023 and 8 December 2023. Completion follows the satisfaction of all Conditions Precedent under the Share Subscription Agreement with Zijin, including shareholder approval on 6 February 2024, and approval by the Foreign Investment Review Board (FIRB) last week. For further information, please contact:Colin Moorhead    Spencer Cole Executive Chairman & Managing Director Chief Financial OfficerP:...

Neve Yarak, Israel, March 04, 2024 (GLOBE NEWSWIRE) — Save Foods, Inc. (NASDAQ: SVFD) (FSE:80W) (“Save Foods”), a pioneer Agri-Food Tech company offering sustainable solutions for agriculture and plant based food, announced today that Plantify Foods, Inc. (TSXV: PTFY) (“Plantify Foods”), a clean label food company dedicated to providing consumers with nutritious and delicious food options, has secured a new retailer, expanding Plantify’s footprint within its local market of Israel. Plantify Foods is a subsidiary which is owned 23% by Save Foods. “The Company continues to secure new retail partners within its local market,” said Suzette Ramcharan, Chief Executive Officer of Plantify Foods. “While we push sales and marketing efforts in new and larger markets such as Europe and the United States, we are pleased...

Infographic 1Infographic 1Infographic 2Infographic 2Infographic 3Infographic 3Infographic 4Infographic 4HIGHLIGHTS:Generation of the updated structural vein/shear Leap Frog model takes into consideration all the surface and drill data collected (incl. oriented core) as well as the number of mineralized pierce points in each vein to date on the Surebet Discovery. This has resulted in an advanced understanding of the mineralized zones that remain open at Surebet, where 10 veins have now been confirmed, including Surebet (now Surebet Upper), Bonanza and Golden Gate; now two stacked Upper and Lower parallel veins (see images below).An accompanying infographic is available at: https://www.globenewswire.com/NewsRoom/AttachmentNg/82cf14d6-3075-44eb-9016-333a9db5ffaf An accompanying infographic is available...

Şişecam plans to invest 114 million dollars in three new coated glass lines. These cutting-edge lines, boasting a collective capacity of nearly 20 million square meters, will be located in Turkey, Italy and BulgariaProf Dr Ahmet KirmanCavaliere Prof Dr Ahmet Kirman – Şişecam’s Chairman and Executive Member of the BoardISTANBUL, Turkey, March 04, 2024 (GLOBE NEWSWIRE) — Şişecam, a global player in the fields of glass and chemicals, has announced its decision to invest 114 million dollars in three new coated glass lines. These cutting-edge lines with a total capacity of almost 20 million square meters will be located in Turkey, Italy, and Bulgaria. Through these investments, Şişecam seeks to address the rising demand for coated glass within the flat glass sector. The Company aims to bolster its competitiveness...

Herzliya Israel, March 04, 2024 (GLOBE NEWSWIRE) — Beamr (Nasdaq: BMR), a leading supplier of video optimization technology and solutions, today issued its annual Letter to Shareholders from Sharon Carmel, Chief Executive Officer of Beamr. Dear Shareholders: As we look toward a promising and exciting year ahead, I am proud to reflect on Beamr’s achievements throughout 2023, including our financial results for 2023, our recent achievements so far in Q1 2024, and look forward to our plans for Q2 2024. 2023 was the year we built the Beamr Cloud service, and 2024 is the year we plan to invest in expansion of our business. Beamr is experiencing a pivotal moment following the launch of the Beamr Cloud SaaS solution, which enables everyone to perform high quality, high scale video processing at attractive pricing. Our new video cloud...

SCOTTSDALE, Ariz., March 04, 2024 (GLOBE NEWSWIRE) — The Joint Corp. (NASDAQ: JYNT), the nation’s largest provider of chiropractic care through The Joint Chiropractic® network, announced that management is scheduled to attend the 36th Annual Roth Conference on March 17th – 19th. The conference is being held at The Ritz Carlton in Dana Point, CA. President and Chief Executive Officer Peter Holt and Chief Financial Officer Jake Singleton will participate in a fireside chat with analyst George Kelly on Tuesday, March 19th at 9:00 am PT. Management will host one-on-one meetings on March 18th and 19th. Interested investors should contact their ROTH representative or Kirsten Chapman of LHA Investor Relations at thejoint@lhai.com. A webcast of management’s presentation will be available live and via replay for a period of 90 days in the...

Recognition honors companies demonstrating business integrity through best-in-class ethics, compliance, and governance practices SPOKANE, Wash., March 04, 2024 (GLOBE NEWSWIRE) — Avista Corp. (NYSE: AVA), a Washington state-based energy company with operations spanning five states, has been recognized by Ethisphere, a global leader in defining and advancing the standards of ethical business practices, as one of the 2024 World’s Most Ethical Companies. Avista has been recognized by Ethisphere for five consecutive years since 2020 and is one of only 8 honorees in the Energy and Utilities industry. In 2024, 136 honorees were recognized spanning 20 countries and 44 industries. “We are honored to be recognized once again as one of the World’s Most Ethical Companies. This year marks Avista’s 135 years of service to our community. Since...

MONTREAL, March 04, 2024 (GLOBE NEWSWIRE) — Osisko Development Corp. (NYSE: ODV, TSXV: ODV) (“Osisko Development” or the “Company“) is pleased to announce the Company has entered into a credit agreement with National Bank of Canada (the “Lender“) providing for a US$50 million delayed draw term loan (the “Credit Facility“), through its wholly-owned subsidiary, Barkerville Gold Mines Ltd. (“Barkerville“). The Credit Facility will be exclusively used to fund ongoing detailed engineering and pre-construction activities at the Company’s 100%-owned Cariboo Gold Project (“Cariboo” or the “Project“) located in central British Columbia (“BC“), Canada. This includes the commencement of an underground development drift from the existing Cow...

LOS ALTOS, Calif., March 04, 2024 (GLOBE NEWSWIRE) — Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company or “Unicycive”), today announced that the U.S. Food and Drug Administration has granted orphan drug designation (ODD) to UNI-494 for the prevention of Delayed Graft Function (DGF) in kidney transplant patients. UNI-494 is a cytoprotective agent that elicits an ischemic preconditioning effect by activating KATP channels in mitochondria to restore mitochondrial function. “We are pleased to announce that the FDA has granted orphan drug designation to UNI-494 for the prevention of delayed graft function after kidney transplantation, an unmet medical need for which there are no FDA-approved drugs,” said Shalabh Gupta, MD, Chief Executive...